Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Schedule of Warrants Outstanding (Details)

v3.20.2
Shareholders' Deficit - Schedule of Warrants Outstanding (Details) - Warrant [Member]
9 Months Ended
Sep. 30, 2020
$ / shares
shares
Shares Outstanding, Beginning Balance | shares 73,486
Shares, Granted | shares
Shares, Cancelled | shares (16,572)
Shares, Exercised | shares
Shares Outstanding, Ending Balance | shares 56,914
Shares Exercisable, Ending Balance | shares 56,914
Weighted-Average Exercise Price, Outstanding Beginning Balance | $ / shares $ 306.28
Weighted-Average Exercise Price, Granted | $ / shares
Weighted average Exercise price, Cancelled | $ / shares 406.21
Weighted-Average Exercise Price, Exercised | $ / shares
Weighted-Average Exercise Price, Outstanding Ending Balance | $ / shares 277.20
Weighted-Average Exercise Price, Exercisable Ending Balance | $ / shares $ 277.20
Weighted Average Remaining Contractual Term (years), Outstanding Beginning 1 year 4 months 13 days
Weighted Average Remaining Contractual Term (years), Outstanding Ending 10 months 3 days
Weighted Average Remaining Contractual Term (years), Exercisable Ending 10 months 3 days